Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. - Brunskill SJ; Hyde CJ; Doree CJ; Watt SM; Martin-Rendon E (European journal of heart failure, 2009)